Congratulations to the team of authors of RIBSP, developers of the first Kazakh vaccine QazCovid-In (QazVac) with another brilliant publication of the results of scientific research obtained as part of the scientific research project “Development of a vaccine against coronavirus infection COVID-19”.
The results of preclinical trials of the inactivated vaccine were published by a group of scientists in the authoritative international journal in the field of microbiology “Frontiers in Microbiology”.
The process of preparing the article was supervised by a young scientist, PhD, head of the laboratory of collection of microorganisms K.D. Zhugunisov.
In experiments on hamsters, the safety and high protective efficacy of QazCovid-In (QazVac) has been proven on used animals.
This publication once again proves the high level of scientific research of the scientists in the field of virology and vaccinology.
The results of the colossal work of scientists – the developed vaccine against COVID-19 “QazCovid-in” is a huge achievement of domestic science and an undeniable contribution to ensuring the biological security of the country!